Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Innovation Pharmaceuticals Inc (IPIX) Message Board

Great, Mo. It's bogus to compare Brilacidin-OM to

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 72447
(Total Views: 375)
Posted On: 04/17/2019 6:26:14 AM
Avatar
Posted By: Drano
Re: Mo #55196
Great, Mo. It's bogus to compare Brilacidin-OM to that old approval statistic and claim that there is only a 55% chance of approval for other reasons in addition to the changes in the FDA's policies

Why do I say that?

Because those statistics include ALL drugs that applied for approval. This means that included in that statistic are all the failed Alzheimer's drugs, schizophrenia drugs, and drugs for other diseases that are notoriously hard to treat and for which a "successful" clinical trial has such low efficacy that the FDA would not approve them -- because the side effects were so severe for so many people, while offering little benefit.
One cannot compare the entire spectrum of drugs, many of which have severe side effects, with Brilacidin-OM, which has NO side effects, and is NOT A SYSTEMIC DRUG but instead is locally applied via swish-and-spit.

Bril-OM's great safety profile is the game changer. Safety will not be a concern for the FDA or EMA. Efficacy will be -- and the Phase 2 results show great efficacy, for a condition that has NO treatment now.

The chance of a drug being approved when there is no current treatment is much, much higher than when there are already some approved treatments.

There is another possibility too --
It's possible that at least in the EU Brilacidin-OM could be considered a MEDICAL DEVICE rather than a drug. There are precedents for other type of medications which are not ingested, but applied internally, to be considered medical devices in the EU. One example is a company that has an antiseptic (not an antibiotic) that is kept in the port when a permanent line is implanted. These ports are notorious for causing serious infections. The antibiotic is kept in the port when it's not being used to introduce a drug to the body -- but removed each time when the port is used. You can see that a swish-and-swallow is much less invasive and has less chance of systemic effect than something like that. Yet, that antiseptic is considered a medical device.

Medical devices have a much, much higher rate of approval, if IPIX chooses to try to follow that root.

The good thing about Lemoncat's bogus claim is that with that post, he has proven what we have known all along -- some basher identities try to masquerade as bulls, until they become panicked enough to show their hand.


(7)
(0)




Innovation Pharmaceuticals Inc (IPIX) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us